Ohara, H.; Harada, Y.; Hiyama, T.; Sadahide, A.; Minamoto, A.; Kiuchi, Y.
Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept. Medicina 2023, 59, 1125.
https://doi.org/10.3390/medicina59061125
AMA Style
Ohara H, Harada Y, Hiyama T, Sadahide A, Minamoto A, Kiuchi Y.
Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept. Medicina. 2023; 59(6):1125.
https://doi.org/10.3390/medicina59061125
Chicago/Turabian Style
Ohara, Hiromi, Yosuke Harada, Tomona Hiyama, Ayako Sadahide, Akira Minamoto, and Yoshiaki Kiuchi.
2023. "Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept" Medicina 59, no. 6: 1125.
https://doi.org/10.3390/medicina59061125
APA Style
Ohara, H., Harada, Y., Hiyama, T., Sadahide, A., Minamoto, A., & Kiuchi, Y.
(2023). Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept. Medicina, 59(6), 1125.
https://doi.org/10.3390/medicina59061125